Cargando…
A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout
BACKGROUND: Although international guidelines encourage urate lowering therapy (ULT) for people who have more than two attacks of gout, only 30 % of patients are prescribed it and only 40 % of those adhere to the treatment. The aim was to explore reasons for this through an exploration of patient ex...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895958/ https://www.ncbi.nlm.nih.gov/pubmed/27267878 http://dx.doi.org/10.1186/s12891-016-1117-5 |
_version_ | 1782435956707557376 |
---|---|
author | Richardson, Jane C. Liddle, Jennifer Mallen, Christian D. Roddy, Edward Hider, Samantha Prinjha, Suman Ziebland, Sue |
author_facet | Richardson, Jane C. Liddle, Jennifer Mallen, Christian D. Roddy, Edward Hider, Samantha Prinjha, Suman Ziebland, Sue |
author_sort | Richardson, Jane C. |
collection | PubMed |
description | BACKGROUND: Although international guidelines encourage urate lowering therapy (ULT) for people who have more than two attacks of gout, only 30 % of patients are prescribed it and only 40 % of those adhere to the treatment. The aim was to explore reasons for this through an exploration of patient experience and understanding of ULT treatment for gout. METHODS: A qualitative study was conducted throughout the United Kingdom. Narrative and semi-structured video-recorded interviews and thematic analysis were used. RESULTS: Participants talked about their views and experiences of treatment, and the factors that affected their use of ULT. The analysis revealed five main themes: 1) knowledge and understanding of gout and its treatment; 2) resistance to taking medication; 3) uncertainty about when to start ULT; 4) experiences of using ULT; and 5) desire for information and monitoring. CONCLUSION: Patients’ understanding and experiences of gout and ULT are complex and it is important for clinicians to be aware of these when working with patients. It is also important for clinicians to know that patients’ perceptions and behaviour are not fixed, but can change over time, with changes to their condition, with dialogue and increased understanding. Patients want this interaction with their clinicians, through “a joint effort over a period of time”. |
format | Online Article Text |
id | pubmed-4895958 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-48959582016-06-08 A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout Richardson, Jane C. Liddle, Jennifer Mallen, Christian D. Roddy, Edward Hider, Samantha Prinjha, Suman Ziebland, Sue BMC Musculoskelet Disord Research Article BACKGROUND: Although international guidelines encourage urate lowering therapy (ULT) for people who have more than two attacks of gout, only 30 % of patients are prescribed it and only 40 % of those adhere to the treatment. The aim was to explore reasons for this through an exploration of patient experience and understanding of ULT treatment for gout. METHODS: A qualitative study was conducted throughout the United Kingdom. Narrative and semi-structured video-recorded interviews and thematic analysis were used. RESULTS: Participants talked about their views and experiences of treatment, and the factors that affected their use of ULT. The analysis revealed five main themes: 1) knowledge and understanding of gout and its treatment; 2) resistance to taking medication; 3) uncertainty about when to start ULT; 4) experiences of using ULT; and 5) desire for information and monitoring. CONCLUSION: Patients’ understanding and experiences of gout and ULT are complex and it is important for clinicians to be aware of these when working with patients. It is also important for clinicians to know that patients’ perceptions and behaviour are not fixed, but can change over time, with changes to their condition, with dialogue and increased understanding. Patients want this interaction with their clinicians, through “a joint effort over a period of time”. BioMed Central 2016-06-06 /pmc/articles/PMC4895958/ /pubmed/27267878 http://dx.doi.org/10.1186/s12891-016-1117-5 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Richardson, Jane C. Liddle, Jennifer Mallen, Christian D. Roddy, Edward Hider, Samantha Prinjha, Suman Ziebland, Sue A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout |
title | A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout |
title_full | A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout |
title_fullStr | A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout |
title_full_unstemmed | A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout |
title_short | A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout |
title_sort | joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895958/ https://www.ncbi.nlm.nih.gov/pubmed/27267878 http://dx.doi.org/10.1186/s12891-016-1117-5 |
work_keys_str_mv | AT richardsonjanec ajointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout AT liddlejennifer ajointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout AT mallenchristiand ajointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout AT roddyedward ajointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout AT hidersamantha ajointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout AT prinjhasuman ajointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout AT zieblandsue ajointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout AT richardsonjanec jointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout AT liddlejennifer jointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout AT mallenchristiand jointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout AT roddyedward jointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout AT hidersamantha jointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout AT prinjhasuman jointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout AT zieblandsue jointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout |